Promino Nutritional Sciences Inc. (MUSL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 7 | 10 | 8 | 9 | 7 |
| Accounts receivable | 729 | 3,138 | -2,388 | -982 | -245 |
| Accounts payable and accrued liabilities | 184 | N/A | N/A | N/A | 548 |
| Other Working Capital | 797 | 6,292 | -823 | -1,311 | 21 |
| Other Operating Activity | -1,628 | -10,006 | 2,879 | -640 | -1,023 |
| Operating Cash Flow | $89 | $-567 | $-323 | $-2,925 | $-692 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -16 | 1 | -2 | -2 |
| Investing Cash Flow | $0 | $-16 | $1 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 210 | N/A | N/A | 201 |
| Debt Issued | 53 | 305 | -181 | 227 | 49 |
| Debt Repayment | -122 | 37 | -6 | -16 | -19 |
| Common Stock Issued | N/A | 0 | 0 | 3,500 | 0 |
| Other Financing Activity | 0 | 0 | 387 | -652 | 250 |
| Financing Cash Flow | $-69 | $553 | $201 | $3,060 | $481 |
| Exchange Rate Effect | 4 | -61 | -178 | -65 | 41 |
| Beginning Cash Position | 3 | 36 | 387 | 320 | 492 |
| End Cash Position | 27 | 3 | 36 | 387 | 320 |
| Net Cash Flow | $20 | $28 | $-173 | $132 | $-214 |
| Free Cash Flow | |||||
| Operating Cash Flow | 89 | -567 | -323 | -2,925 | -692 |
| Capital Expenditure | N/A | -16 | -2 | -2 | -2 |
| Free Cash Flow | 89 | -583 | -325 | -2,927 | -695 |